The impact of premature discontinuation of antidepressant therapy in major depressive disorder in the UK

被引:0
|
作者
Beard, SM
Earnshaw, SR
Gaffney, L
Hogue, SL
Krishnan, AA
机构
[1] RTI Hlth Solut, Manchester, Lancs, England
[2] RTI Hlth Solut, Raleigh, NC USA
[3] GlaxoSmithKline, Raleigh, NC USA
关键词
D O I
10.1016/S1098-3015(10)66082-2
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:779 / 779
页数:1
相关论文
共 50 条
  • [21] Differential change on depressive symptom factors with antidepressant medication and cognitive behavior therapy for major depressive disorder
    Dunlop, Boadie W.
    Cole, Steven P.
    Nemeroff, Charles B.
    Mayberg, Helen S.
    Craighead, W. Edward
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2018, 229 : 111 - 119
  • [22] Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis
    Masaki Kato
    Hikaru Hori
    Takeshi Inoue
    Junichi Iga
    Masaaki Iwata
    Takahiko Inagaki
    Kiyomi Shinohara
    Hissei Imai
    Atsunobu Murata
    Kazuo Mishima
    Aran Tajika
    [J]. Molecular Psychiatry, 2021, 26 : 118 - 133
  • [23] Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis
    Kato, Masaki
    Hori, Hikaru
    Inoue, Takeshi
    Iga, Junichi
    Iwata, Masaaki
    Inagaki, Takahiko
    Shinohara, Kiyomi
    Imai, Hissei
    Murata, Atsunobu
    Mishima, Kazuo
    Tajika, Aran
    [J]. MOLECULAR PSYCHIATRY, 2021, 26 (01) : 118 - 133
  • [24] Multimodal antidepressant in Major Depressive Disorder: Use of vortioxetine in depressive outpatients
    Santamaria, O.
    Romero, S. L.
    [J]. EUROPEAN PSYCHIATRY, 2018, 48 : S279 - S280
  • [25] Efficacy of Antidepressant Medication in the Treatment of Major Depressive Disorder
    Anderson, Benjamin
    Muller, Andrew
    [J]. ARCHIVES OF CLINICAL PSYCHIATRY, 2023, 50 (01) : 123 - 129
  • [26] ANTIDEPRESSANT RESPONSE IN MAJOR DEPRESSIVE DISORDER AND RARE VARIANTS
    Wong, Ma-Li
    Arcos-Burgos, Mauricio
    Licinio, Julio
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : 1304 - 1304
  • [27] Antidepressant adherence among outpatients with major depressive disorder
    Yassen, Ali Omar
    Mahmud, Nasraw Mustafa
    Bilal, Aya Diyar
    Wahab, Mohd Shahezwan Abd
    [J]. PHARMACIA, 2024, 71
  • [28] Inadequate Response to Antidepressant Treatment in Major Depressive Disorder
    Papakostas, George I.
    Jackson, W. Clay
    Rafeyan, Roueen
    Trivedi, Madhukar H.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (03)
  • [29] Vortioxetine: a novel antidepressant for the treatment of major depressive disorder
    Gonda, Xenia
    Sharma, Samata R.
    Tarazi, Frank I.
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2019, 14 (01) : 81 - 89
  • [30] Personalized antidepressant treatment for patients with major depressive disorder
    Chin, Tracy
    Huyghebaert, Trudy
    Svrcek, Clark
    Oluboka, Oloruntoba
    [J]. CANADIAN FAMILY PHYSICIAN, 2022, 68 (11) : E301 - E309